E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega,Eugene Braunwald,Stephen D. Wiviott,Jean-Pierre Bassand,Deepak L. Bhatt,Christoph Bode,Paul Burton,Marc Cohen,Nancy Cook-Bruns,Shinya Goto,Sabina A. Murphy,Alexei N. Plotnikov,David J. Schneider,Xiang Sun,C. Michael Gibson +14 more
TL;DR: In patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke in a double-blind, placebo-controlled trial.
Journal ArticleDOI
Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
Elliott M. Antman,Milenko J. Tanasijevic,Bruce Thompson,Mark Schactman,Carolyn H. McCabe,Christopher P. Cannon,George A. Fischer,Anthony Fung,Christopher R. Thompson,Donald R. Wybenga,Eugene Braunwald +10 more
TL;DR: In patients with acute coronary syndromes, cardiac troponin I levels provide useful prognostic information and permit the early identification of patients with an increased risk of death.
Book
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
TL;DR: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition - Libros de Medicina - Cardiologia clinica - 196,000
Journal ArticleDOI
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Laura Mauri,Dean J. Kereiakes,Robert W. Yeh,Priscilla Driscoll-Shempp,Donald E. Cutlip,P. Gabriel Steg,P. Gabriel Steg,Sharon-Lise T. Normand,Eugene Braunwald,Stephen D. Wiviott,David J. Cohen,David R. Holmes,Mitchell W. Krucoff,James B. Hermiller,Harold L. Dauerman,Daniel I. Simon,David E. Kandzari,Kirk N. Garratt,David P. Lee,Thomas K. Pow,Peter Ver Lee,Michael J. Rinaldi,Joseph M. Massaro,Joseph M. Massaro +23 more
TL;DR: Dual antiplatelet therapy beyond 1 year after placement of a drug-eluting stent, as compared with aspirin therapy alone, significantly reduced the risks of stent thrombosis and major adverse cardiovascular and cerebrovascular events but was associated with an increased risk of bleeding.
Journal ArticleDOI
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca,Deepak L. Bhatt,Marc Cohen,Philippe Gabriel Steg,Robert F. Storey,Eva C. Jensen,Giulia Magnani,Sameer Bansilal,M. Polly Fish,KyungAh Im,Olof Bengtsson,Ton Oude Ophuis,Andrzej Budaj,Pierre Theroux,Mikhail Ruda,Christian W. Hamm,Shinya Goto,Jindrich Spinar,Jose C. Nicolau,Róbert Gábor Kiss,Sabina A. Murphy,Stephen D. Wiviott,Peter Held,Eugene Braunwald,Marc S. Sabatine +24 more
TL;DR: In patients with a myocardial infarction more than 1 year previously, treatment with ticagrelor significantly reduced the risk of cardiovascular death, my Cardiac Infarction, or stroke and increased therisk of major bleeding.